company update on the following then It should be ASX...

company update on the following then It should be ASX requirements that any delay in business plans should be explained to the market

Ie - delays in trail numbers - what are they doing to get sufficent test subjects ? no update from the company leaves investors in limbo and hte SP suffers

Why and how does this delay the FDA approval and how long now do they think it will take

What steps and R and D are being taken on the next stage products

Cash flow update is the spending on target or do they have cost savings or cost blowouts on the trials.

Email the company if worreid and the ASX asking that they ask the company if anything of market sensitive nature has changed and if what you say is correct then the ASX should follow up - the ASX in a lot of cases dont have the resources to cover all companies but will follow up emails from investors as a priority regarding possible changes in market sensitive information.